Cardinal Health, Inc. company logo

# 1st Gen Model Cardinal Health, Inc. Drugs, proprietaries, & sundries

Subscribe >> Deal exit on
July 21, 2017
Deal entry on
July 21, 2017
0.45%Expected margin
66.67% successful of 42 deals
$76.29 Last close price
at 21-jul-2017

CAH

Model's trade recommendations 2.28% Return for period

-10.82% Annual return

$24.32B Market Cap

β 0.81  

CAH

Model (following trade recommendations)

CAH

Underlying stock

S&P 500

Index
Return for period 2.28%
-4.25%
1.78%
52wk return -22.65%
-8.07%
16.82%
52wk Range
65.17—84.92
2000.54—2399.63
Sortino ratio -0.91
Sharpe ratio -0.88
Norm. RMSE 0.32%
Downside risk 12.01%
Volatility 12.49%
  • 1.85 (2.40%) Div (Yield)
  • HOLD Analysts consensus recommendation

Cardinal Health, Inc. is one of the leading providers of products and services to healthcare providers and manufacturers to help them improve the efficiency and quality of healthcare. These services and products include Pharmaceutical Distribution and Provider Services, Medical-Surgical Products and Services, Pharmaceutical Technologies and Services and Automation and Information Services.

Industry sector: Medical

Sector classification: Drugs, proprietaries, & sundries

Deep Learning based analysis and prediction model for Cardinal Health, Inc. (CAH) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for CAH model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 313M
P/E 14.67
Shares Outstanding 316M
% Held by Insiders 0.94%
% Held by Institutions 87.52%
EPS (last reported FY) $5.24
EPS (last reported Q) $1.53
EPS, estimated (last reported Q) $1.46
Total revenues $122 B
Net income $1 B